Products
Online Inquiry
MCC-555
Cat. No.:
0225LY-0898
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
MCC-555 targets both PPARα and PPARγ as an agonist to produce significant antihyperglycemic effects.
Synonym:
Isaglitazone; Netoglitazone; 161600-01-7; 5-((6-((2-Fluorobenzyl)oxy)naphthalen-2-yl)methyl)thiazolidine-2,4-dione; 5-[[6-[(2-fluorophenyl)methoxy]naphthalen-2-yl]methyl]-1,3-thiazolidine-2,4-dione; 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-2,4-thiazolidinedione; 2,4-Thiazolidinedione, 5-((6-((2-fluorophenyl)methoxy)-2-naphthalenyl)methyl)-; (5RS)-5-((6-((2-Fluorobenzyl)oxy)-2-naphthyl)methyl)thiazolidine-2,4-dione; (5RS)-5-[[6-[(2-Fluorobenzyl)oxy]-2-naphthyl]methyl]thiazolidine-2,4-dione; 5-({6-[(2-fluorophenyl)methoxy]naphthalen-2-yl}methyl)-1,3-thiazolidine-2,4-dione
CAS No.:
161600-01-7
Compound CID:
204109
Formula:
C21H16FNO3S
Formula Weight:
381.42
Specification
Relative Density:
1.369 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
MCC-555 can be used in diabetes research to explore the modulation of PPAR gamma-mediated gene transcription.
Library Information
Target:
PPAR
Receptor:
PPARα; PPARγ
Pathways:
Metabolism; DNA damage/DNA repair
Plate Number:
AOCL-12
Plate Location:
e7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
250 mg/mL; 655.45 mM
